JP Renew Distributors LLC (JPRD) - Distributing SEANOL® Formulations

SEANOL Overview and Advantages

JP Renew, JPRD, Seanol, JPRenew, cava ecklonia, ecklonia cava, kajime,distribution, japan

SEANOL combines a patented extraction process with a powerful source of marine polyphenols/phlorotannins—the brown algae, Ecklonia cava—to create a highly effective and safe ingredient with a compelling range of applications.

The extraction process enhances SEANOL’s safety by removing arsenic, iodine and other heavy metals found in marine extracts. This has resulted in SEANOL being approved for use under some of the most strictly regulated food safety standards applied throughout the world.

SEANOL is the result of 15 years of extensive pre-clinical and clinical research and over $30 million dollars of investment. Numerous clinical studies in the U.S., Japan, and Korea support the health benefits of SEANOL.

SEANOL’s unique molecular structure makes SEANOL significantly more potent in many applications when compared to other marine and land-based polyphenol extracts.

The complex structure of SEANOL makes it an extremely potent electron (free radical) absorbing mechanism. SEANOL’s hydrophobic chemistry gives it a long half-life and also allows it to pass through the blood-brain barrier.

JP Renew, JPRD, seanol, JPRenew, distribution, japan

SEANOL Benefits and Applications

The multitude of health benefits arising from the efficacy of SEANOL’s unique properties make it a viable ingredient for inclusion many forms of products targeting various health and aging conditions.

Evidence and full reports for the SEANOL benefits can be found in the Science and Research section.

SEANOL Development History

The SEANOL story goes back to a union of three Ph.D’s who were working on drug developments in cardiovascular and Alzheimer’s diseases at the University of Iowa in the late 1980's. By the beginning of the 1990’s, they started to doubt the conventional method of drug development which focuses only on strong inhibition of specific biochemical processes, leading often to more harm than benefit. This was especially true of chronic degenerative diseases such as CAD, CVD, DM, arthritis, Alzheimer’s, allergies, cancers, etc..

One of the researchers happened to have an interest in the physiological actions of second metabolites of land and sea plants. After 5 years of his research focused primarily on compounds from seaweeds, he announced his success in isolation of several new antioxidant compounds from edible seaweeds. The three researchers confirmed the seaweed extracts’ great potential as a superior natural agent with absolute safety and long-term efficacy in age-related chronic degenerative diseases.

They subsequently raised a total of $30 million in Korean government and private funding from 1999 through 2004 to perform further R&D. During this period, the researchers performed countless in vitro, in vivo and clinical trials in an attempt to determine for which indications the polyphenols worked most effectively. In that phase, they discovered that SEANOL had many superior properties beneficial to human vascular problems (cardio-, cerebro-, and penile), obesity, arthritis, allergies and dementia.

Their work is covered by many patents, both issued and pending.